U.S., Feb. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07387666) titled 'Imaging Acetadote Metabolism in Glioblastoma' on Jan. 27.
Brief Summary: This goal of this clinical trial is to evaluate how Acetadote affects metabolism in patients with glioblastoma. Drugs like Acetadote, which affect the level of damage in a cell (oxidative stress), may impact brain tumor metabolism and slow the growth of brain tumors.
We are evaluating how Acetadote affects glioblastoma metabolism by using MRI-based methods and by determining the changes in metabolism in brain tumor tissue resected from patients with a new diagnosis of glioblastoma.
Study Start Date: July 01, 2026
Study Type: INTERVENTIONAL
Condition:
Gliobl...